Bharat Parenterals Ltd Financials
Company Logo

Bharat Parenterals Ltd Financial Statement

Bharat Parenterals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue82.54
Operating Expense75.70
Net Profit2.28
Net Profit Margin2.76
Earning Per Share3.48
EBIDTA6.91
Effective Tax Rate19.44

Bharat Parenterals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual254.16
Operating Expenses Annual225.73
Operating Profit Annual40.39
Interest Annual3.19
Depreciation6.40
Net Profit Annual22.59
Tax Annual8.21

Bharat Parenterals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning6.34
Cash Flow from Operations-22.92
Cash Flow from Investing-16.10
Cash Flow from Financing34.17
Cash Flow at the End1.50

Bharat Parenterals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)14.52
PBIT Margin (%)12.26
PBT Margin (%)9.14
Net PROFIT Margin (%)7.98
Return On Networth / Equity (%)11.16
Return On Networth /Employed (%)12.94
Return On Assets (%)8.45
Total Debt / Equity (X)0.32
Asset Turnover Ratio (%)1.06

Bharat Parenterals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual38.47
Total Current Assets Annual218.16
Non Current Assets Annual168.99
Total Shareholders Funds Annual213.61
Total Assets Annual387.15

Bharat Parenterals Ltd Earning Calls

EPS (INR)

Expected

-6.87

Reported

-14.40

Surprise

109.61%

Dec 2024

EPS beaten by 109.61%

Sep 2024

EPS beaten by 314.94%

Jun 2024

EPS beaten by 0.00%

FAQS on Bharat Parenterals Ltd Financials

As of May 12, 2025, Bharat Parenterals Ltd has a market capitalization of 680.55 Cr. Value Research classifies it as a Small-Cap company.
Yes, Bharat Parenterals Ltd is debt-free with a debt-to-equity ratio of 0.17.
In FY 2024 , Bharat Parenterals Ltd recorded a total revenue of approximately 304.13 Cr marking a significant milestone in the company's financial performance.
Bharat Parenterals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.6% and 0.2% annually, respectively..
Bharat Parenterals Ltd's current PE ratio is 25.73.
Bharat Parenterals Ltd's ROCE averaged 11.7% from the FY ending March 2023 to 2025, with a median of 11.6%. It peaked at 14.5% in March 2023, reflecting strong capital efficiency over the period..
Bharat Parenterals Ltd's latest EBIT is Rs. 41.09 Cr, surpassing the average EBIT of Rs. 36.68 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions